Frost & Sullivan

Quintiles named to Fortune magazine's 2015 list of World’s Most Admired Companies

Thursday, February 26, 2015 01:05 PM

Quintiles, a biopharmaceutical services company, has been named to Fortune magazine’s World’s Most Admired Companies list for 2015.

More... »


Oncology and infectious diseases forecast as top investment areas for 2015

Thursday, January 15, 2015 01:39 PM

Oncology, cardiovascular, autoimmune/anti-inflammatories and infectious diseases will be the top areas of investments in 2015, according to a report by global growth consulting firm Frost & Sullivan.

More... »


Report: Turkish life sciences industry draws outside investors, pharma

Thursday, January 15, 2015 01:36 PM

Big pharmaceutical companies and foreign investors are flocking to Turkey to capitalize on its encouraging economic policies, according to global growth consulting firm Frost & Sullivan. The establishment of technology development zones that exempt pharmaceutical entrepreneurs and academics from income taxes until 2023 has played a particularly crucial role in driving R&D activity in the life sciences industry.

More... »

Report: Global stem cell market to reach $118B by 2018

Wednesday, December 3, 2014 01:02 PM

The global stem cell market earned revenues of $40.01 billion in 2013 and is estimated to nearly triple to $117.66 billion in 2018 at a compound annual growth rate (CAGR) of 24.1%, according to a new analysis from Frost & Sullivan. The study covers human adult and embryonic stem cells. While North America is the market leader with more than half of the global stem cell market share, Asia-Pacific is expected to record the highest CAGR during the forecast period. In fact, the APAC stem cell market, which was valued at $5.6 billion in 2013, is projected to increase to $18.71 billion by 2018.

More... »

Frost & Sullivan honors Clinical Ink for eSource platform that streamlines clinical development

Friday, September 5, 2014 10:56 AM

Based on its recent analysis of the eClinical solutions market, Frost & Sullivan recognizes Clinical Ink with the 2014 North American eClinical Solutions Award for Entrepreneurial Company of the Year. The award recognizes Clinical Ink's innovative SureSource platform—the first purpose-built eSource solution that captures data electronically at the point of care.

More... »

Report: Drug developers drawn to orphan drugs market, create competitive pipelines

Friday, March 28, 2014 03:08 PM

New analysis from Frost & Sullivan's Product and Pipeline Assessment of the Global Orphan Drugs Market identifies rare cancers as the orphan therapeutic area with the highest level of drug development activity. Other disease areas witnessing considerable drug development activity include blood/lymphatic system diseases, infectious/parasitic diseases, neurological diseases, metabolic diseases and immunological/inflammatory diseases.

More... »

Report: Latin American diabetes therapeutics market to transform

Wednesday, February 19, 2014 01:27 PM

The Latin American diabetes therapeutics market will experience major changes within the next three years due to the launch of innovative drugs that include three long-acting insulins and four non-insulin treatments. Nevertheless, pharmaceutical companies should continue their research to develop treatments that can restore beta-cell function and thereby postpone or prevent disease progression—areas that even newer therapies do not address.

More... »

Frost & Sullivan predict growth in mHealth, cloud computing and regulatory environment

Wednesday, December 4, 2013 12:53 PM

Frost & Sullivan has made its three big predictions for the global healthcare market. Based on a 2013 Search for Growth survey of 1,835 executives in more than 40 countries, Frost & Sullivan have said key areas of growth in 2014 and beyond will be in mHealth, cloud computing and regulatory environments.

More... »

SIRO Clinpharm named Indian CRO of the Year 2012

Monday, October 1, 2012 09:20 AM

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

More... »

Radiant Sage receives Customer Value Enhancement Award from Frost & Sullivan

Monday, August 20, 2012 03:27 PM

Radiant Sage, a provider of on-demand clinical trial image management solutions based in Belmont, Mass., has received the Frost & Sullivan 2012 Customer Value Enhancement Award for its clinical trial image management solutions.

More... »


CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs